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The importance of right ventricular (RV) function in maintaining global cardiac perfor-
mance is the focus ofthis discussion. The physiological determinants ofnormal rightventricular
function will be discussed, with particular emphasis on the afterload and contractility character-
istics of the right ventricle. Numerous clinical conditions have been shown to affect RV
performance. These conditions include positive-pressure ventilation, ischemia, pulmonary
hypertension, and cardiac surgery. Present methods for the perioperative evaluation of RV
function include angiography, radionuclide techniques, thermodilution techniques, echocardi-
ography, and magnetic resonance imaging. Traditional modalities for the treatment of RV
dysfunction consist of pharmacological interventions (i.e., vasodilators and inotropes) and/or
mechanical assist devices. Newer pharmacological strategies for the treatment of RV failure
and associated pulmonary hypertension include the phosphodiesterase fraction III inhibitors
and the prostaglandins, specifically PGE,. In summary, the accurate evaluation ofperioperative
RV performance combined with new treatment options will ensure maximal preservation of
RV performance.
Attention is presently being focused on the importance of right ventricular
function (RV) and the factors that influence right ventricular performance during
the perioperative period. Historically, a more complete understanding of RV func-
tion has been limited by the perception that the contractile performance ofthe RV is
hemodynamically unimportant. Initial research by Starr et al. reported no detectable
impairment on overall cardiac performance with complete destruction of the RV
free wall in dogs [1]. New investigations, however, have demonstrated that, in the
presence of elevated right ventricular preload or afterload, septic shock, coexistent
left ventricular dysfunction or right coronary artery (RCA) occlusive disease, the
function of the RV becomes hemodynamically significant [2,3]. As a result, the
diagnosis and treatment of RV failure represent a challenging clinical problem.
PHYSIOLOGY OF RIGHT VENTRICULAR FUNCTION
The importance of right ventricular function becomes apparent during the intra-
uterine period, when it serves as the predominant ventricle. As a result of the
foramen ovale and the ductus arteriosus, the right ventricle shares a similar preload
and afterload with the left ventricle but ejects approximately 66 percent of the
295
Abbreviations: ARDS: adult respiratory distress syndrome EKG: electrocardiogram IVS: interven-
tricular septum LAD: left anterior descending LV: left ventricular LVAD: left ventricular assist
devices LVEDV: left ventricular end diastolic volume NMI: nuclear magnetic imaging PABC:
pulmonary artery balloon counterpulsation PAH: pulmonary artery hypertension PCWP: pulmonary
capillary wedge pressure PEEP: positive end-expiratory pressure PVR: pulmonary vascular resis-
tance RA: right atrium RCA: right coronary artery RV: right ventricular RVEDP: right ventricular
end diastolic pressure RVEF: right ventricular ejection fraction RVMI: right ventricular infarction
Copyright © 1991 by The Yale Journal ofBiology and Medicine, Inc.
All rights of reproduction in any form reserved.ROBERTA HINES
cardiac output. During this early stage of growth and development, the total
coronary blood flow to the left and the rightventricle is similar, and flow per gram of
myocardium is identical [4]. With the decrease in pulmonary vascular resistance
(PVR) that occurs at birth (with the closure of the foramen ovale and the ductus
arteriosus), however, the work ofeach ventricle dramaticallychanges. This decrease
in PVR is accompanied by a reduction in RV pressure and coronary blood flow, with
a concomitant increase in left ventricular (LV) myocardial blood flow. As a result,
the left ventricle quickly develops into a thick-walled, highly contractile chamber. In
contrast, the right ventricle becomes a thin-walled, highly compliant, but poorly
contractile chamber.
The blood supply to the right ventricle is derived predominantly from the right
coronary artery (RCA), which supplies the right ventricular free wall on the
posterior, right lateral, and anterior surfaces ofthe heart. In addition, the RCA also
supplies the inferiorone-third ofthe interventricular septum. Moreover, the RV also
receives blood supply from the left anterior descending (LAD) branch of the left
coronary artery. The LAD is also responsible for supplying part of the anterior left
ventricular free wall and the anterior two-thirds of the interventricular septum. The
timingofright coronaryblood flow is unique, in that flow occurs duringboth diastole
and systole [5]. This process is in contrast to the LV, which receives the majority of
coronary flow only during diastole. Many authors have proposed this "dual source"
of RV coronary blood flow as a reason for the relatively small percentage of
significant RV dysfunction that is seen evenwith significant occlusion ofthe RCA.
Unlike the LV, which has a relatively simple mechanism of contraction, the
contraction pattern ofthe rightventricle occurs in three distinct phases [6]. The first
involves contraction ofthe spiral muscles. The second involves movement ofthe RV
free wall toward the interventricular septum. Finally, the third phase is completed as
the leftventricle contracts, causing a "wringer" actionwhich further aids in emptying
the rightventricular cavity.
Right ventricular performance is influenced both by intrinsic factors such as the
contractile state of the RV myocardium and by extrinsic factors. These extrinsic
factors include: preload, afterload, constraining effects ofthe pericardium, intraperi-
cardiac pressure, right coronary artery perfusion pressure, left ventricular perfor-
mance, and the contractile state of the interventricular septum. Therefore the
maintenance of normal RV function depends both on those intrinsic factors that
determine RV contractile performance and extrinsic factors which determine RV
pump performance. As such, under certain loadingconditions, failure ofthe RV as a
pump may occur in the absence of any depression in myocardial contractility.
Conversely, the presence of depressed myocardial contractility may be obscured by
favorable loading conditions, resulting in no discernible impairment in RV pump
function.
Right ventricular function is exquisitely sensitive to any increases in afterload [7].
The thin-walled right ventricular cavity compensates poorly for any such increases.
In comparison to the left ventricle, which maintains a relatively constant output over
a wide range of afterloads, the output of the RV abruptly decreases with minimal
alterations in afterload (Fig. 1) [7]. Clinically, this process becomes manifest as a
progressive decrease in RV ejection, which has particular significance in situations
where increases in RV afterload (i.e., increased pulmonary artery pressure or
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FIG. 1. The effects of varying afterload and preload are seen in these ventricular function curves from
the right and the left ventricle. As a result of the highly compliant nature of the RV, afterload changes are
poorly tolerated. As may be seen from this figure, even small increases in RV afterload result in dramatic
decreases in RV function (as measured by a decreased stroke volume). (Reproduced with permission
from [6].)
increased pulmonary vascular resistance) occur. Such conditions would include
management of patients with pulmonary artery hypertension, pulmonary embolus,
mitral valve disease (with secondary pulmonary artery hypertension), and the adult
respiratory distress syndrome.
MECHANISMS OF VENTRICULAR INTERDEPENDENCE
Although the interventricular septum (IVS) is usually considered functionally part
of the left ventricle, Taylor and other investigators have shown the importance ofthe
functional interaction between the left and right ventricles by means of the location
of the interventricular septum [8]. This interaction results in alterations of the
diastolic and systolic function of each ventricle. In a canine preparation, with the
right ventricle distended by 50 ml of blood, aliquots of blood presented to the left
ventricle eere associated with a progressive increase in the right ventricular end
diastolic pressure. Similarly, removal of blood from the right ventricle reduced left
ventricular pressure. This relationship may have great clinical importance, as defined
in the work ofLaver and colleagues, who adopted the term "ventricular interference"
or ventricular interdependence to describe the importance of the location and
contractility of the interventricular septum in maintaining normal cardiac geometry
[9]. The hemodynamic effect of this ventricular interaction is more pronounced with
the pericardium intact, although more subtle changes are seen when the pericardium
is removed [10,11].ROBERTA HINES
Ordinarily, increased pulmonary capillary wedge pressure (PCWP) associated
with a decreased cardiac output is diagnostic of left ventricular failure. Under
conditions where pulmonary artery pressure is increased, however, right ventricular
end diastolic volume and pressure are also increased. This change results in a shift of
the interventricular septum into the left ventricular cavity and reduction in left
ventricular end diastolic volume. In this particular case, rather than functioning as
part of the left ventricle, the interventricular septum is physiologically associated
with the right ventricle, resulting in an "internal tamponade." In a clinical study,
using two-dimensional echocardiography, Jardin and colleagues showed the impor-
tance of this mechanism for reduction in cardiac output ofpatients receiving positive
end expiratory pressure in an intensive care unit [12].
Abnormalities of left ventricular function such as coronary artery disease, conges-
tive heart failure, valvular heart disease, and systemic hypertension all influence
right ventricular function, depending on the degree to which they affect RV diastolic
volume, RV systolic function, and RV afterload. In addition, the systolic pressure of
one ventricle will influence the systolic pressure of the other. In an experimental
animal, acute obstruction to left ventricular outflow (without any change in the
volume status), resulted in an elevated right ventricular systolic pressure [13].
THE DIAGNOSTIC EVALUATION OF RIGHT VENTRICULAR
PERFORMANCE
Any system which allows for the routine measurement of RV volumes would
enhance diagnostic capabilities and lead to the development of new therapeutic
strategies for the treatment of RV dysfunction. In the past, central venous pressure
measurement has served as the "gold standard" for recording RV pressure and
volume measurements. Depending upon the compliance changes of the RV and/or
abnormalities in the tricuspid valve apparatus, however, central venous pressure may
be an inadequate predictor of changes in right ventricular end diastolic volume and
pressure. In addition, the poor correlation between ventricular end diastolic volumes
and ventricular end diastolic pressure relationships (in the left ventricle) has been
demonstrated in recent reports by Calvin et al. [14]. Therefore, rather than relying
entirely on pressure measurements as a guide to RV performance, the determination
of RVvolumes is essential in assessing RV performance.
Several of the diagnostic and therapeutic modalities which have been developed
for the evaluation of left ventricular volume have been utilized for the measurement
of right ventricular volume. Present techniques available for evaluation of RV
volume include: angiography, echocardiography, radionuclide methods, thermodilu-
tion, and, recently, magnetic resonance imaging. The accurate estimate of RV
volumes by angiography relies upon the development of a single geometric model.
Because ofthe anatomic variability ofthe RV, depending upon the angle from which
it is viewed, it has been described as a pyramid, an ellipse, or a tetrahedron;
therefore, development of a standardized technique has been difficult. In addition,
angiography often poses a significant risk due to the pharmacological properties of
currently available contrast media. Also, each study necessitates the injection of an
additional osmotic load, which may be poorly tolerated by seriously ill patients.
To avoid some of the problems encountered with angiography, radionuclide
techniques (based on time-activity relationships) have been developed. Two com-
monly employed radionuclear techniques are: the first-pass technique and the
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equilibrium-gated pool scan. Both allow the determination of several parameters,
including ejection fraction, systolic ejection time, peak filling rates, peak ejection
fraction, and rate of contractility [15,16]. The first-pass technique facilitates the
measurement of these parameters during a single cycle and is based upon the
principles of indicator dilution therapy [14]. The major advantage of the first-pass
technique is the spatial separation of the right atrium from the right ventricle,
especially in the right anterior oblique projection. Homogenous mixing of the
radioactive tracer is necessary, however, for proper performance of this technique.
Therefore, any artifacts encountered (for example, dysrhythmias, or tricuspid regur-
gitation) may invalidate the results obtained with this method. A separate injection
of radioactive tracer is required for each first-pass study, and, as a result, patients are
subjected to large amounts of radioactive material if several studies are needed.
Development of new short half-life tracers such as gold 195m may allow numerous
sequential first-pass studies to be performed without the accumulation of the
radioactive tracer [17]. The equilibrium-gated pool utilizes labeled red cells for
evaluation ofrightventricular function and allows repeated measurementswith only
a single bolus injection of radioactive tracer [18]. Byusing a computer, approximately
five minutes of heartbeats are collected and gated to the electrocardiogram (EKG);
an averaged cycle is constructed to represent right ventricular ejection fraction
(RVEF). This technique is ideally suited to the perioperative assessment of RV
function. Because isotope is present in all four cardiac chambers, however, it is often
difficult to separate right atrial from right ventricular activity, resulting in an
inaccurate measurement of RVEF (often as much as 20 percent) [18]. Despite their
limitations, these two radionuclear methods have been used quite effectively for the
evaluation ofperioperative right ventricular function.
In addition to the above-mentioned radionuclear techniques, both M-mode and
2-D echocardiography have been employed to investigate right ventricular function
[19]. Ultrasound provides useful information regarding RV dimensions and the
movement of the IVS; however, echocardiographic assessment of the right ventricle
has several limitations. These difficulties are related to the shape of the right
ventricular cavity and the fact that its location is directly below the echo-dense
sternum, which acoustically "hides" the RV. The development of 2-D transesoph-
ageal echocardiography may allow a more precise visualization of the RV, but this
problem warrants further investigation [20].
A new technique has been developed for the determination of RV volumes, one
which combines the principles of the indicator dilution theory and use of a rapid-
response thermistor pulmonary artery flow catheter [21]. Kay and colleagues have
validated this technique, using radionuclear studies both in an animal model and in
patients following open heart surgery [22]. The response of the standard thermistor-
tipped pulmonary artery catheter is between 300 and 1,000 milliseconds. This
catheter is equipped with a "rapid-response" thermistor (50-millisecond), which
provides the measurement of temperature variation. A typical thermal washout
cardiacoutput curve generatedbythis method allows the measurement ofchanges in
temperature associated with successive diastolic plateaus (Fig. 2). Computation of
the right ventricular ejection fraction (RVEF) is then easily performed. (Normal
thermodilution RVEF is approximately 40 percent.) RVEF, stroke volume, end
diastolicvolume, and end systolicvolume may be easily calculated.
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EF=1 -RF
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FIG. 2. A representative thermodilution cardiac output curve obtained with rapid-response
thermistor pulmonary artery catheter (50 msec). Cl, C2, C3 represent temperature differences
between successive diastole plateaus. RF = residual fraction; EF = ejection fraction.
(Reproduced with permission from [22].) Using an algorithm right ventricular fraction
(RVEF), measures are easily calculated. Normal RVEF by this technique = 40 percent.
cardiac output
stroke volume = hartrate heart rate
stroke volume
end diastolic volume = ejection fraction
end systolic volume = end diastolic volume - stroke volume
Thus, from a standard RVEF catheter, the clinician will gain knowledge of cardiac
output, right ventricular ejection fraction, pulmonary artery and capillary wedge
pressures, and right ventricular pressures as well as right atrial pressure.
There are, however, two specific limitations to the use of this technique. The first
involves patients with cardiac dysrhythmias, such as atrial fibrillation; variations in
diastolic filling time may introduce errors into the measurement of right ventricular
ejection fraction. The right ventricular ejection fraction is computed within four to
five beats, however, and therefore an average RVEFmaybe obtained. In addition, in
patients with regurgitant valvular lesions, especially tricuspid insufficiency, an erro-
neous RVEF may be seen, since this technique measures only forward flow.
Placement of the thermistor in the atrium will, however, facilitate calculation of the
regurgitant fraction.
The technique ofnuclear magnetic imaging (NMI) has recently been employed as
the newest method for assessing myocardial performance. This technique has been
extremely effective in its ability to evaluate RV architecture and size. In addition, the
tricuspid valves as well as the end systolic and end diastolic RV volumes are easily
visualized. Using this technique, the epicardial surface of the RV is clearly demon-
strated, permitting a more qualitative assessment ofthe complex RV geometry.
CLINICAL IMPLICATIONS
The importance of monitoring RV function becomes apparent in several clinical
situations; these include patients with chronic obstructive pulmonary disease, adult
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respiratory distress syndrome, patients requiring mechanical ventilation, and pa-
tients receiving a protamine infusion. Matthay and Berger have demonstrated RV
dysfunction in patients with chronic obstructive pulmonary disease, using radionu-
clear stress testing [23]. Abnormal elevations in RV systolic and pulmonary artery
pressures were noted in these patients in response to exercise.
In the management of patients with adult respiratory distress syndrome (ARDS),
knowledge ofright ventricular function is also clinically useful [24]. Regardless ofthe
etiology ofARDS, RV dysfunction usually occurs as a result of increasing afterload,
secondary to pulmonary artery hypertension. Sibbald et al. examined biventricular
function in patients with ARDS and found a negative correlation between right
ventricular ejection fraction and the mean pulmonary artery pressure [25]. This
increase in pulmonary artery pressure has also been associated with a depression of
right ventricular contractility. It has been proposed that, with increasing RV end
diastolic volume, an increase in wall stress may develop, predisposing the RV to
subendocardial ischemia [19]. The degree of pulmonary artery hypertension neces-
sary for the development of ischemia and resultant RV failure has not yet been
determined.
Various modes of mechanical ventilation may also impair RV performance. By
increasing afterload, changes in ventilatory mode may influence RV hemodynamics.
Jardin et al. have shown that mechanical ventilation with positive end-expiratory
pressure (PEEP) (30 cm H20) produces a shift of the interventricular septum with
paradoxical motion resulting in right heart dilatation and decreased left ventricular
chamber size [12]. New data also reveal that, in post-operative ventilated patients, a
decrease in RVEF is observed at PEEP levels greater than 15 cmH2O [26]. Further-
more, changes in ventilatory modes (i.e., intermittent mandatory or assist control)
may further alter right heart function. Studies demonstrate that right ventricular
ejection fraction is most impaired with assist-controlled ventilation and is least
affected by intermittent mandatory or spontaneous ventilation [27]. Recently, high-
frequency jet ventilation has been reported to cause less hemodynamic instability
than traditional modes of mechanical ventilation. Its effect on right ventricular
performance had not, however, been fully evaluated until a recent report by Biondi
et al. [28]. They demonstrated the effect of airway pressure on right ventricular
ejection fraction. A significant inverse correlation was noted between RVEF (ther-
mal) and increasing amounts of airway pressure delivered by the high-frequency jet
ventilator.
The effect of right ventricular ischemia and/or infarction on global cardiac
performance is presently being studied. Hines et al. evaluated right ventricular
function in patients undergoing coronary artery bypass surgery [20,29]. Based upon
angiographic data, patients were classified according to the degree of stenosis
present in the right coronary artery (RCA). Subsets were defined as those having less
than 90 percent stenosis, or those with greater than or equal to 90 percent stenosis of
the right coronary artery. In the group of patients with greater than 90 percent
stenosis of the RCA, a statistically significant increase in RVEF was observed, fol-
lowing coronary artery revascularization. In addition, the same subset of patients
were at increased risk for development of right ventricular ischemia. The earliest
signs ofrightventricular dysfunction were manifested as elevations ofright ventricu-
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lar end diastolic pressure, accompanied by a decrease in RVEF (in the face of a
normal PCWP) [30].
The importance ofmonitoring RV function intra-operatively has been illustrated
byreports ofRV failurefollowingprotamine infusion. Protamine administration has
been associated with right ventricular failure and subsequent cardiac decompensa-
tion. Numerous studies imply a predominant vasodilating response as the principal
eventresponsible formyocardial dysfunction observed following protamine adminis-
tration [31]. A report by Lowenstein et al. suggests, however, that pulmonary
vasoconstriction (versus systemic vasodilatation) following protamine infusion may
be the primary and principal event leading to right ventricular failure [32]. Lowen-
stein and co-workers described five patients who developed severe hemodynamic
instability when intravenous protamine was infused following cardiopulmonary
bypass [32]. To ascertain if protamine infusion was associated with alterations in
right ventricularperformance on anepisodic or a consistent basis, Hines and Barash
evaluated both right and left ventricular function in patients undergoing open heart
surgery [33]. No statistically significant changes in RVEF, systemic blood pressure,
meanpulmonaryarterypressure, orpulmonaryvascular resistance were noted at any
point during the study. In the patients undergoing coronary artery bypass surgery,
right ventricular end diastolicpressure (RVEDP) did not significantly increase from
the baseline. Similarly, in thepatients withvalvular heart disease, the pre-protamine
right ventricular end diastolic pressure continued unchanged throughout the study.
These values remained statistically unchanged following protamine infusion. To
ascertain whetherpulmonary artery hypertension was an additional risk factor, they
examined right and left ventricular function in a subset of patients with pulmonary
arteryhypertension (PAH) greater than 25 mmHg. Even in these high-risk patients,
right ventricular performance, as measured by RVEDP and RVEF, failed to reveal
anypredictable deterioration in RVfunction during or following protamine infusion.
More recent evidence implies an anaphylactoid response, resulting in the activation
of the complement cascade as the principal etiology of pulmonary vasoconstriction
and RV dysfunction following protamine administration [34].
Patients undergoing cardiac surgery present several unique problems regarding
RVperformance. In situations where pre-operative RV hypertrophy is the result of
chronic pulmonary hypertension, the RV will have a limited ability to respond to
even minimal increases in pulmonary resistance. Cooling of the RV is technically
difficult, due to the accumulation of non-coronary collateral blood in the RA and
RV. Also the RV is (from the thesbeian veins and bronchial system) more suscepti-
ble to ambient temperatures and subsequent rewarming by radiant energy from
roomlights and manualmanipulation. In addition, direct injuries to the right atrium
(RA) and RV are common as a result of direct or indirect mechanical trauma.
Following cardiopulmonary bypass, the institution of positive-pressure ventilation
mayimposehigh levels ofpressure on an already non-compliant pulmonary vascula-
ture,resulting in acute RVdysfunction. Finally, intracoronary air is more likely to be
distributed to the native RCA artery and/or RCA graft (due to its anterior and
superior location) than into the LCA system. Recent reports by Greeley et al. have
demonstrated that intracoronary air (following cardiopulmonary bypass) may result
in acute intra-operative RV dysfunction [35].
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METHODS FOR THE DIAGNOSIS AND DETECTION OF RV ISCHEMIA
Cohn and co-workers first described the clinical sequelae of right ventricular
infarction (RVMI) in 1974 [36]. Subsequently, interest in the subset ofpatients with
RVMI has rapidly increased. Although isolated rightventricular infarction is uncom-
mon, there is a high incidence (20-60 percent) of right ventricular involvement in
patients with inferior leftventricular infarctions.
The early signs of right ventricular ischemia are often difficult to detect using
traditional electrocardiographic lead placement systems. Standard intra-operative
monitoring for leftventricular ischemia utilizes a leadV5 in combination with lead II.
Because of the location of the RV, however, this method provides a very limited
electrocardiographic view of the right ventricle. New lead placement systems have
been developed to increase the specificity and sensitivity for RV ischemia detection.
One such system utilizes a V4R lead (a V4R lead is placed in the fourth intercostal
space in the right midclavicular line). Klein et al. have determined the sensitivity and
specificity of using lead V4R for detecting right ventricular ischemia [37]. Using
radionuclide studies and echocardiography to verify the presence of RV dysfunction
seen by EKG, they found that a V4R lead is a highly specific means ofmonitoring for
RV ischemia.
MANAGEMENT OF RV FAILURE
Management of the patient with right ventricular failure remains controversial.
Hemodynamics of RV failure include: (1) primary increased right atrial and right
ventricular end diastolic pressures, (2) normal left atrial and left ventricular end
diastolic pressures, and (3) decreased cardiac output. Treatment strategies have
emphasized: (1) volume loading, (2) vasodilators, (3) inotropic support, (4) vasocon-
strictor, (5) mechanical assist devices, and (6) maintenance of normal atrioventricu-
larconduction. The appropriate sequences ofthe therapeutic intervention depend in
large part on the status ofthe pulmonaryvascular resistance (i.e., RV afterload).
Volume expansion is the foundation oftreatment in situations ofRV failure when
the pulmonary vascular resistance is normal. This increased volume, in the normal
highly compliant RV, will create maximal RV myocardial fiber stretch and maintain
cardiac output. In this situation, the dilation of the RV is the major compensatory
mechanism for augmenting RV contractility. When volume loading alone is insuffi-
cient as diagnosed by (right atrial pressure . 12 mmHg) pulmonaryvasodilators and
inotropic agents (Table 1), which allow for increased RV contractility and/or
pulmonary vasodilatation directly, must be added. The rationale for the treatment
scheme is based upon the fact that RV preload will be maximized at a RA 2 12
mmHg. When an augmentation in preload is insufficient to increase RV perfor-
mance, then pulmonary vasodilatation or inotropes must be added to maximize RV
performance.
Much debate has centered around the practice of using volume expansion as the
primary treatment modality in the settingofacute respiratory failure with associated
pulmonary hypertension. Prewitt and Ghignone investigated the hemodynamic
effects offluid therapy in the setting ofincreased pulmonary vascular resistance and
ARDS [24]. Using equilibrium scintigraphic techniques, the end diastolic and end
systolic areas of both the left and the right ventricles were measured. When
pulmonary vascular resistance (PVR) was normal, volume loading resulted in an
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TABLE 1
Pharmacological Management of Right Ventricular
Dysfunction
Pulmonary Vasodilators Inotropic Agents
Terbutaline Dopamine
Oxygen Dobutamine
Aminophylline Epinephrine
Prostaglandin (PGE,) Isoproterenol
Prostacyclin Amrinone
Nitroglycerin Neosynephrine
Amrinone
increased cardiac output. When increased PVR (PApressure) waspresent, however,
volume expansion resulted in RV failure, documented by decreasing cardiac output
and an increase in right ventricular end diastolic pressure. They postulated that the
increases in PVR, in combination with increased RV volumes, resulted in increased
RV wall stress and subsequent decreases in RV contractility. Thus, volume expan-
sion further increased myocardial oxygen requirements, leading to RV dysfunction
secondary to ischemia. In summary, adult respiratory distress syndrome complicated
by pulmonary artery hypertension (PAH), is associated with a reduction in RVEF
and an increase in RV end diastolic volumes and may be associated with RV
contractile dysfunction. Therefore, in situations where pulmonary vasculature resis-
tance is increased, treatment with pulmonary vasodilators may improve cardiac
output bydecreasingboth RVafterload and PVR and decreasingleftventricular end
diastolicvolume (LVEDV) [38].
The importance ofvasoconstrictor therapy (to maintain RVperfusion pressure) in
the treatment of RV dysfunction has been shown by Laver [39]. He produced RV
dysfunction in a canine model of myocardial ischemia by a progressive occlusion of
the main pulmonary artery. This process was accompanied by apronounced increase
in RVEDP. Infusion of phenylephrine resulted in a dramatic increase in the aortic
diastolic pressure, thereby improving right ventricular perfusion. Subsequently,
Ghignone et al. supported the efficacy ofvasoconstrictor therapy (norepinephrine)
in the treatment of low cardiac output associated with elevation in right ventricular
afterload [40]. In this animal model with elevated RV afterload (PVR), volume
infusion resulted in a decrease in aortic pressure. In contrast, norepinephrine
infusion produced a decrease in biventricular filling pressures and an increase in
cardiac output. The comparative effects ofvolume loading, dobutamine, and nitro-
prusside were evaluated in patients with acute RV infarction [41]. Volume loading
alone did not improve cardiac index in these patients, despite a rise in cardiac filling
pressures. Following appropriate volume loading, however, the administration of
dobutamine produced a significant improvement in cardiac index and RVEF in
comparison to those measurements obtained using a combination of volume and
nitroprusside. These data illustrate that, if increases in PVR are associated with a
reduction in cardiac output, the combination of inotropic and vasodilator therapy
will be necessary to restore RVperformance.
New modes ofpharmacological therapy have been advocated for the treatment of
RV failure. D'Ambra et al. have reported their results, using the infusion of
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prostaglandin E, to dilate the pulmonary vasculature and improve RV function in
patients undergoing mitral valve replacement [42]. High doses ofPGE, were used in
combinationwith left atrial norepinephrine infusion in five consecutive patientswith
refractory right heart failure and pulmonary artery hypertension. The use ofPGE,
resulted in a reduction ofpulmonary vascular resistance and an increase in cardiac
index. Recently, the type III phosphodiesterase inhibitors (i.e., Amrinone) have
been successfully utilized to reduce PVR and augment RV function in patients
undergoing coronary artery bypass surgery and mitral valve replacements [43].
In addition to the pharmacological management of right ventricular dysfunction,
the use of mechanical assist devices (right atrial to pulmonary artery pumping) has
also been suggested. One such devicewas initiallyused to treat post-cardiotomy right
ventricular failure [44]. This device costs over $12,000 per pump, however, and its
restricted use by the FDA makes it unavailable for most centers performing cardiac
surgery. A promising alternative is right atrial to pulmonary artery bypass pumping,
using a Bio Medicus (standard roller pump) centrifugal pump. Miller et al. have
successfully utilized the pulmonary artery balloon counterpulsation (PABC) device
towean a patient with RVdysfunction from cardiopulmonarybypass [45]. PABC has
been effective in RV failure due to pulmonary hypertension, RV infarction, and
global cardiac failure. Left ventricular assist devices (LVAD) may also further
augment RV performance.
Normal atrioventricular conduction and contraction are essential for maintaining
normal RV function. Any loss of sinoatrial activity contributes to a decrease in RV
efficiency in much the samewaythat loss ofthe atrial "kick" decreases LVefficiency.
As new evidence demonstrating the importance ofRVfunction becomesavailable,
diagnostic and therapeutic strategies will be developed which make possible earlier
detection and treatment ofrightventricular dysfunction.
Much remains tobe learned regarding the assessment ofRVperformance and the
identification of factors responsible for RV dysfunction. Recognizing that the
integrity ofthe RV can be altered by numerous perioperative factors is the first step
in developing a systematic approach formonitoring RV function.
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